Gazette Mail | Charleston Drug for rare form of Lou Gehrig's disease OK'd by FDA Metro Valley • Apr 26, 2023
WVNews | Business BioGeNe Series 2023: A Platform for Pharmaceutical, Biotechnology Professionals and Technology Providers (San Diego, United States - February 8-9, 2023) - ResearchAndMarkets.com West Virginia Business • Dec 13, 2022
WVNews | Business Biosimilar Lymphocyte Modulator Global Market Report 2022: Featuring Pfizer, Biogen, Genentech, Novartis & Celltrion - ResearchAndMarkets.com West Virginia Business • Nov 14, 2022
Daily Mail on West Virginia U.S. Supreme Court turns away Biogen bid to reinstate MS drug patent West Virginia Non-Local Sources • Oct 3, 2022
Register Herald | Beckley Alzheimer's drug shows promise in early results of study New River & Greenbrier Valley • Sep 28, 2022
WVNews | Business $964 Billion Worldwide Biotechnology Industry to 2027 - Featuring Amgen, Biogen, Novartis and Pfizer Among Others - ResearchAndMarkets.com West Virginia Business • Aug 3, 2022
WVNews | Business Global microRNA Industry Report 2022-2027 Featuring Profiles of Thermo Fisher Scientific, Horizon Discovery, QIAGEN, BioGenex, and GeneCopoeia Among Others - ResearchAndMarkets.com West Virginia Business • Jul 13, 2022
Daily Mail on West Virginia Boston scientist, 38, who flew from US to her native China while infected with COVID-19 in March and took medication to mask her symptoms, is handed a suspended... West Virginia Non-Local Sources • Jan 26, 2021
Daily Mail on West Virginia U.S. court rules in favor of Mylan over Biogen's key MS drug patent West Virginia Non-Local Sources • Jun 18, 2020
WVNews | Business Pemphigus Vulgaris, Pipeline Review, H2 2019 - Biogen Inc, Declion Pharmaceuticals Inc, Novartis AG & Pharmapraxis - ResearchAndMarkets.com West Virginia Business • Jan 21, 2020
WVNews | Business Growth Differentiation Factor 8, Pipeline Review, H2 2019 - Biogen Inc, PeptiDream Inc, Pfizer & Regeneron Pharmaceuticals Inc - ResearchAndMarkets.com West Virginia Business • Jan 17, 2020
WVNews | Business Banner Life Sciences Receives Favorable Ruling Against Biogen in Patent Infringement Challenge West Virginia Business • Jan 9, 2020
WVNews | Business 2019 Glomerulonephritis Pipeline Review, H2 - Biogen Inc, Omeros Corp, Pfizer Inc & Visterra Inc - ResearchAndMarkets.com West Virginia Business • Jan 9, 2020
WVNews | Business Platelet BioGenesis Receives $2.3 Million Award from the Medical Technology Enterprise Consortium to Accelerate Development of Donor-Independent Platelet Production West Virginia Business • Dec 16, 2019
WVNews | Business US stocks edge higher on company earnings; Biogen surges West Virginia Business • Oct 22, 2019
WVNews | Business Global Central Nervous System (CNS) Drugs Market Analysis, 2014-2022 Featuring Biogen, Roche, Johnson & Johnson, Pfizer, and Novartis - ResearchAndMarkets.com West Virginia Business • Sep 24, 2019
WVNews | Business Platelet BioGenesis Raises $26 Million in Series A-1 Financing West Virginia Business • Sep 9, 2019
WVNews | Business Global Multiple Sclerosis Therapeutics Market Outlook to 2025 - Key Players are Biogen, Teva Pharmaceuticals, Bayer, Sanofi Genzyme, Novartis, and Pfizer - ResearchAndMarkets.com West Virginia Business • Aug 2, 2019
WVNews | Business Gazyva (obinutuzumab; Roche/Biogen/Chugai/Nippon Shinyaku) Overview 2019: A Third-Generation, Type II Glycoengineered, Humanized Anti-CD20 Monoclonal Antibody (MAb)... West Virginia Business • Jul 12, 2019
WVNews | Business Biosimilars: The Importance of Real-World Evidence (2019) Featuring Sandoz, Avalere, and Biogen - ResearchAndMarkets.com West Virginia Business • Jun 25, 2019
WVNews | Business High School Student from Pennsylvania Receives Top Honor at International BioGENEius Challenge West Virginia Business • Jun 4, 2019
WVNews | Business BioGENEius Challenge Announces 2019 Mentor of the Year Awardee West Virginia Business • Jun 1, 2019
WVNews | Business Elite High School Scientists Headed to BIO 2019 to Face Off in the BioGENEius Challenge West Virginia Business • May 30, 2019